NDC 0078-0682-66
Tafinlar 50 mg/1
dabrafenib · CAPSULE
Tafinlar (dabrafenib) is an oral prescription capsule used to treat certain types of cancer, particularly melanoma and other cancers with specific genetic mutations. It works by blocking proteins that help cancer cells grow and divide.
Key Facts
- Brand Name
- Tafinlar
- Generic Name
- dabrafenib
- NDC Code (Package)
0078-0682-66- NDC Code (Product)
0078-0682- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 50 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA202806
- Marketing Start
- 04/12/2016
Recall History
No Recall HistoryView Full Drug Page
Tafinlar — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.